Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 1 , Pages 191-206 , February 2008

Developmental disorders of the hypothalamus and pituitary gland associated with congenital hypopituitarism

  • Ameeta Mehta, MBBS, DCH, MD, DNBE, MRCP, MSC, MD (Clinical Research Fellow, Developmental Endocrinology Research Group)
  • Mehul T. Dattani, MBBS, DCH, FRCPCH, FRCP, MD (Professor and Consultant in Paediatric Endocrinology, Developmental Endocrinology Research Group)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 20 79052657; Fax: +44 20 74046191.

References 

  1. Dattani MT, Robinson IC. The molecular basis for developmental disorders of the pituitary gland in man. Clinical Genetics. 2000;57(5):337–346
  2. Cohen LE, Radovick S. Molecular basis of combined pituitary hormone deficiencies. Endocrine Reviews. 2002;23(4):431–442
  3. Dasen JS, Rosenfeld MG. Signaling and transcriptional mechanisms in pituitary development. Annual Review of Neuroscience. 2001;24:327–355
  4. Zhu X, Zhang J, Tollkuhn J, et al. Sustained Notch signaling in progenitors is required for sequential emergence of distinct cell lineages during organogenesis. Genes and Development. 2006;20(19):2739–2753
  5. Dattani MT, Martinez-Barbera JP, Thomas PQ, et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nature Genetics. 1998;19(2):125–133
  6. Thomas PQ, Dattani MT, Brickman JM, et al. Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Human Molecular Genetics. 2001;10(1):39–45
  7. Zhadanov AB, Bertuzzi S, Taira M, et al. Expression pattern of the murine LIM class homeobox gene Lhx3 in subsets of neural and neuroendocrine tissues. Developmental Dynamics. 1995;202(4):354–364
  8. Schmitt S, Biason-Lauber A, Betts D, et al. Genomic structure, chromosomal localization, and expression pattern of the human LIM-homeobox3 (LHX 3) gene. Biochemical and Biophysical Research Communications. 2000;274(1):49–56
  9. Sheng HZ, Moriyama K, Yamashita T, et al. Multistep control of pituitary organogenesis. Science. 1997;278(5344):1809–1812
  10. Machinis K, Amselem S. Functional relationship between LHX4 and POU1F1 in light of the LHX4 mutation identified in patients with pituitary defects. The Journal of Clinical Endocrinology and Metabolism. 2005;90(9):5456–5462
  11. Sobrier ML, Attie-Bitach T, Netchine I, et al. Pathophysiology of syndromic combined pituitary hormone deficiency due to a LHX3 defect in light of LHX3 and LHX4 expression during early human development. Gene Expression Patterns. 2004;5(2):279–284
  12. Semina EV, Reiter R, Leysens NJ, et al. Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nature Genetics. 1996;14(4):392–399
  13. Solomon NM, Ross SA, Morgan T, et al. Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3. Journal of Medical Genetics. 2004;41(9):669–678
  14. Solomon NM, Nouri S, Warne GL, et al. Increased gene dosage at Xq26-q27 is associated with X-linked hypopituitarism. Genomics. 2002;79(4):553–559
  15. Laumonnier F, Ronce N, Hamel BC, et al. Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency. American Journal of Human Genetics. 2002;71(6):1450–1455
  16. Woods KS, Cundall M, Turton J, et al. Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. American Journal of Human Genetics. 2005;76(5):833–849
  17. Kelberman D, Rizzoti K, Avilion A, et al. Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo–pituitary–gonadal axis in mice and humans. The Journal of Clinical Investigation. 2006;116(9):2442–2455
  18. Williamson KA, Hever AM, Rainger J, et al. Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome. Human Molecular Genetics. 2006;15(9):1413–1422
  19. Sornson MW, Wu W, Dasen JS, et al. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature. 1996;384(6607):327–333
  20. Olson LE, Tollkuhn J, Scafoglio C, et al. Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination. Cell. 2006;125(3):593–605
  21. Ward RD, Raetzman LT, Suh H, et al. Role of PROP1 in pituitary gland growth. Molecular Endocrinology. 2005;19(3):698–710
  22. Li S, Crenshaw EB, Rawson EJ, et al. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature. 1990;347(6293):528–533
  23. Andersen B, Rosenfeld MG. POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. Endocrine Reviews. 2001;22(1):2–35
  24. Wu W, Cogan JD, Pfaffle RW, et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nature Genetics. 1998;18(2):147–149
  25. Cogan JD, Wu W, Phillips JA, et al. The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. The Journal of Clinical Endocrinology and Metabolism. 1998;83(9):3346–3349
  26. Deladoey J, Fluck C, Buyukgebiz A, et al. ‘Hot spot’ in the PROP1 gene responsible for combined pituitary hormone deficiency. The Journal of Clinical Endocrinology and Metabolism. 1999;84(5):1645–1650
  27. Turton JP, Mehta A, Raza J, et al. Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD). Clinical Endocrinology. 2005;63(1):10–18
  28. Fofanova OV, Takamura N, Kinoshita E, et al. A mutational hot spot in the Prop-1 gene in Russian children with combined pituitary hormone deficiency. Pituitary. 1998;1(1):45–49
  29. Mendonca BB, Osorio MG, Latronico AC, et al. Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301, G302 in the PROP1 gene. The Journal of Clinical Endocrinology and Metabolism. 1999;84(3):942–945
  30. Parks JS, Brown MR, Hurley DL, et al. Heritable disorders of pituitary development. The Journal of Clinical Endocrinology and Metabolism. 1999;84(12):4362–4370
  31. Asteria C, Oliveira JH, Abucham J, et al. Central hypocortisolism as part of combined pituitary hormone deficiency due to mutations of PROP-1 gene. European Journal of Endocrinology. 2000;143(3):347–352
  32. Pernasetti F, Toledo SP, Vasilyev VV, et al. Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of Pit-1 gene. The Journal of Clinical Endocrinology and Metabolism. 2000;85(1):390–397
  33. Riepe FG, Partsch CJ, Blankenstein O, et al. Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation. The Journal of Clinical Endocrinology and Metabolism. 2001;86(9):4353–4357
  34. Agarwal G, Bhatia V, Cook S, et al. Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion. The Journal of Clinical Endocrinology and Metabolism. 2000;85(12):4556–4561
  35. Vallette-Kasic S, Barlier A, Teinturier C, et al. PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. The Journal of Clinical Endocrinology and Metabolism. 2001;86(9):4529–4535
  36. Voutetakis A, Argyropoulou M, Sertedaki A, et al. Pituitary magnetic resonance imaging in 15 patients with Prop1 gene mutations: pituitary enlargement may originate from the intermediate lobe. The Journal of Clinical Endocrinology and Metabolism. 2004;89(5):2200–2206
  37. Tatsumi K, Miyai K, Notomi T, et al. Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nature Genetics. 1992;1(1):56–58
  38. Cohen LE, Wondisford FE, Salvatoni A, et al. A ‘hot spot’ in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates. The Journal of Clinical Endocrinology and Metabolism. 1995;80(2):679–684
  39. Holl RW, Pfaffle R, Kim C, et al. Combined pituitary deficiencies of growth hormone, thyroid stimulating hormone and prolactin due to Pit-1 gene mutation: a case report. European Journal of Pediatrics. 1997;156(11):835–837
  40. Aarskog D, Eiken HG, Bjerknes R, et al. Pituitary dwarfism in the R271W Pit-1 gene mutation. European Journal of Pediatrics. 1997;156(11):829–834
  41. Rodrigues Martineli AM, Braga M, De Lacerda L, et al. Description of a Brazilian patient bearing the R271W Pit-1 gene mutation. Thyroid. 1998;8(4):299–304
  42. Ward L, Chavez M, Huot C, et al. Severe congenital hypopituitarism with low prolactin levels and age-dependent anterior pituitary hypoplasia: a clue to a PIT-1 mutation. The Journal of Pediatrics. 1998;132(6):1036–1038
  43. Turton JP, Reynaud R, Mehta A, et al. Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency (CPHD). The Journal of Clinical Endocrinology and Metabolism. 2005;90:4762–4770
  44. Tornqvist K, Ericsson A, Kallen B. Optic nerve hypoplasia: risk factors and epidemiology. Acta Ophthalmologica Scandinavica. 2002;80(3):300–304
  45. Patel L, McNally RJ, Harrison E, et al. Geographical distribution of optic nerve hypoplasia and septo-optic dysplasia in Northwest England. The Journal of Pediatrics. 2006;148(1):85–88
  46. Arslanian SA, Rothfus WE, Foley TP, et al. Hormonal, metabolic, and neuroradiologic abnormalities associated with septo-optic dysplasia. Acta Endocrinologica. 1984;107(2):282–288
  47. Morishima A, Aranoff GS. Syndrome of septo-optic-pituitary dysplasia: the clinical spectrum. Brain and Development. 1986;8(3):233–239
  48. Nanduri VR, Stanhope R. Why is the retention of gonadotrophin secretion common in children with panhypopituitarism due to septo-optic dysplasia?. European Journal of Endocrinology. 1999;140(1):48–50
  49. Pagon RA, Stephan MJ. Septo-optic dysplasia with digital anomalies. The Journal of Pediatrics. 1984;105(6):966–968
  50. Orrico A, Galli L, Zappella M, et al. Septo-optic dysplasia with digital anomalies associated with maternal multidrug abuse during pregnancy. European Journal of Neurology. 2002;9(6):679–682
  51. Harrison IM, Brosnahan D, Phelan E, et al. Septo-optic dysplasia with digital anomalies–a recurrent pattern syndrome. American Journal of Medical Genetics. Part A. 2004;131(1):82–85
  52. Brickman JM, Clements M, Tyrell R, et al. Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development. 2001;128(24):5189–5199
  53. Cohen RN, Cohen LE, Botero D, et al. Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia. The Journal of Clinical Endocrinology and Metabolism. 2003;88(10):4832–4839
  54. Carvalho LR, Woods KS, Mendonca BB, et al. A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction. The Journal of Clinical Investigation. 2003;112(8):1192–1201
  55. Tajima T, Hattorri T, Nakajima T, et al. Sporadic heterozygous frameshift mutation of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient. The Journal of Clinical Endocrinology and Metabolism. 2003;88(1):45–50
  56. Sobrier ML, Netchine I, Heinrichs C, et al. Alu-element insertion in the homeodomain of HESX1 and aplasia of the anterior pituitary. Human Mutation. 2005;25(5):503
  57. Sobrier ML, Maghnie M, Vie-Luton MP, et al. Novel HESX1 mutations associated with a life-threatening neonatal phenotype, pituitary aplasia, but normally located posterior pituitary and no optic nerve abnormalities. The Journal of Clinical Endocrinology and Metabolism. 2006;
  58. Wales JK, Quarrell OW. Evidence for possible Mendelian inheritance of septo-optic dysplasia. Acta Paediatrica. 1996;85(3):391–392
  59. Rainbow LA, Rees SA, Shaikh MG, et al. Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia. Clinical Endocrinology. 2005;62(2):163–168
  60. McNay DE, Turton JP, Kelberman D, et al. HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. The Journal of Clinical Endocrinology and Metabolism. 2007;92(2):691–697
  61. Murray PG, Paterson WF, Donaldson MD. Maternal age in patients with septo-optic dysplasia. Journal of Pediatric Endocrinology and Metabolism. 2005;18(5):471–476
  62. Roessler E, Du YZ, Mullor JL, et al. Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(23):13424–13429
  63. Netchine I, Sobrier ML, Krude H, et al. Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nature Genetics. 2000;25(2):182–186
  64. Bhangoo AP, Hunter CS, Savage JJ, et al. Clinical case seminar: a novel LHX3 mutation presenting as combined pituitary hormonal deficiency. The Journal of Clinical Endocrinology and Metabolism. 2006;91(3):747–753
  65. Pfaeffle RW, Savage JJ, Hunter CS, et al. Four novel mutations of the LHX3 gene cause combined pituitary hormone deficiencies with or without limited neck rotation. The Journal of Clinical Endocrinology and Metabolism. 2007;92(5):1909–1919
  66. Machinis K, Pantel J, Netchine I, et al. Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. American Journal of Human Genetics. 2001;69(5):961–968
  67. Mehta A, Hindmarsh PC, Stanhope RG, et al. The role of growth hormone in determining birth size and early postnatal growth, using congenital growth hormone deficiency (GHD) as a model. Clinical Endocrinology. 2005;63(2):223–231
  68. Mehta A, Hindmarsh PC, Stanhope RG, et al. Is the thyrotropin-releasing hormone test necessary in the diagnosis of central hypothyroidism in children. The Journal of Clinical Endocrinology and Metabolism. 2003;88(12):5696–5703
  69. Mehta A, Hindmarsh PC, Dattani MT. An update on the biochemical diagnosis of congenital ACTH insufficiency. Clinical Endocrinology. 2005;62(3):307–314

PII: S1521-690X(07)00062-0

doi: 10.1016/j.beem.2007.07.007

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 1 , Pages 191-206 , February 2008

Article Tools

* Image Usage & Resolution